RPAP2 and hepatocellular carcinoma: As an HSP90 client, high levels of RPAP2 sensitized HCC cells to HSP90 inhibitors, and the ectopic expression of RPAP2 restored the response to HSP90 inhibitors in SNU‐423 cells with undetectable levels of RPAP2 (Figure 5H,I).